TMO

TMO Operating Cash Flow (Statement)

$9.01BTTM · USD

Period ending:

TMO FY Cash from OperationsUSD
TMO FY Cash from Operations1989-12-31: $47.60M1990-12-31: $18.60M1991-12-31: $23.00M1992-12-31: $54.90M1993-12-31: $126.70M1994-12-31: $204.20M1995-12-31: $194.60M1996-12-31: $224.50M1997-12-31: $269.00M1998-12-31: $328.50M1999-12-31: $337.12M2000-12-31: $199.92M2001-12-31: $188.40M2002-12-31: $102.89M2003-12-31: $216.72M2004-12-31: $264.51M2005-12-31: $270.91M2006-12-31: $405.65M2007-12-31: $1.48B2008-12-31: $1.42B2009-12-31: $1.66B2010-12-31: $1.50B2011-12-31: $1.69B2012-12-31: $2.04B2013-12-31: $2.01B2014-12-31: $2.62B2015-12-31: $2.82B2016-12-31: $3.16B2017-12-31: $4.01B2018-12-31: $4.54B2019-12-31: $4.97B2020-12-31: $8.29B2021-12-31: $9.54B2022-12-31: $9.15B2023-12-31: $8.41B2024-12-31: $8.67B2025-12-31: $7.82B$9.54B$0.00
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TMO operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

Thermo Fisher Scientific Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
7,818,000,000
8,667,000,000
8,406,000,000
9,154,000,000
9,543,000,000
8,289,000,000
4,973,000,000
4,543,000,000
4,005,000,000
3,156,300,000
2,816,900,000
2,619,600,000
2,010,700,000
2,039,500,000
1,691,000,000
1,497,800,000
1,659,200,000
1,420,200,000
1,483,500,000
405,654,000
270,913,000
264,510,000
216,719,000
102,892,000
188,401,000
199,921,000
337,121,000
328,500,000
269,000,000
224,500,000
194,600,000
204,200,000
126,700,000
54,900,000
23,000,000
18,600,000
47,600,000

Compare operating cash flow (statement)

All TMO financial metrics · TMO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.